Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(PD L1). Showing records 1 – 30 of 83 total matches.

[1] [2] [3]

Search Limiters

Last 2 Years | English Only

Degrees

Country

▼ Search Limiters


Queens University

1. Black, Madison. The PD-1/PD-L1 Axis: An Immune-Mediated Mechanism of Chemoresistance in Cancer .

Degree: Anatomy and Cell Biology, 2015, Queens University

 The ability of tumour cells to avoid immune destruction (immune escape) and their acquired resistance to anti-cancer drugs constitute important barriers to the successful management… (more)

Subjects/Keywords: Chemoresistance ; PD-1/PD-L1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Black, M. (2015). The PD-1/PD-L1 Axis: An Immune-Mediated Mechanism of Chemoresistance in Cancer . (Thesis). Queens University. Retrieved from http://hdl.handle.net/1974/13145

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Black, Madison. “The PD-1/PD-L1 Axis: An Immune-Mediated Mechanism of Chemoresistance in Cancer .” 2015. Thesis, Queens University. Accessed January 19, 2021. http://hdl.handle.net/1974/13145.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Black, Madison. “The PD-1/PD-L1 Axis: An Immune-Mediated Mechanism of Chemoresistance in Cancer .” 2015. Web. 19 Jan 2021.

Vancouver:

Black M. The PD-1/PD-L1 Axis: An Immune-Mediated Mechanism of Chemoresistance in Cancer . [Internet] [Thesis]. Queens University; 2015. [cited 2021 Jan 19]. Available from: http://hdl.handle.net/1974/13145.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Black M. The PD-1/PD-L1 Axis: An Immune-Mediated Mechanism of Chemoresistance in Cancer . [Thesis]. Queens University; 2015. Available from: http://hdl.handle.net/1974/13145

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Queens University

2. Ling, Min. IDENTIFICATION AND CHARACTERIZATION OF NOVEL KINASES REGULATING PROGRAMMED DEATH LIGAND-1 (PD-L1) IN IMMUNE EVASION OF TRIPLE NEGATIVE BREAST CANCER CELLS .

Degree: Pathology and Molecular Medicine, Queens University

 The programmed death ligand-1 (PD-L1) is an immune checkpoint protein expressed on a variety of antigen-presenting cells to normalize immune system. Recently, overexpression of PD-L1(more)

Subjects/Keywords: PD-L1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ling, M. (n.d.). IDENTIFICATION AND CHARACTERIZATION OF NOVEL KINASES REGULATING PROGRAMMED DEATH LIGAND-1 (PD-L1) IN IMMUNE EVASION OF TRIPLE NEGATIVE BREAST CANCER CELLS . (Thesis). Queens University. Retrieved from http://hdl.handle.net/1974/28007

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Ling, Min. “IDENTIFICATION AND CHARACTERIZATION OF NOVEL KINASES REGULATING PROGRAMMED DEATH LIGAND-1 (PD-L1) IN IMMUNE EVASION OF TRIPLE NEGATIVE BREAST CANCER CELLS .” Thesis, Queens University. Accessed January 19, 2021. http://hdl.handle.net/1974/28007.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Ling, Min. “IDENTIFICATION AND CHARACTERIZATION OF NOVEL KINASES REGULATING PROGRAMMED DEATH LIGAND-1 (PD-L1) IN IMMUNE EVASION OF TRIPLE NEGATIVE BREAST CANCER CELLS .” Web. 19 Jan 2021.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Ling M. IDENTIFICATION AND CHARACTERIZATION OF NOVEL KINASES REGULATING PROGRAMMED DEATH LIGAND-1 (PD-L1) IN IMMUNE EVASION OF TRIPLE NEGATIVE BREAST CANCER CELLS . [Internet] [Thesis]. Queens University; [cited 2021 Jan 19]. Available from: http://hdl.handle.net/1974/28007.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Ling M. IDENTIFICATION AND CHARACTERIZATION OF NOVEL KINASES REGULATING PROGRAMMED DEATH LIGAND-1 (PD-L1) IN IMMUNE EVASION OF TRIPLE NEGATIVE BREAST CANCER CELLS . [Thesis]. Queens University; Available from: http://hdl.handle.net/1974/28007

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


University of Melbourne

3. Hogg, Simon John. BET bromodomain inhibition as combined apoptotic and immunomodulatory therapy for the treatment of MYC-driven lymphoma.

Degree: 2017, University of Melbourne

 Bromodomain and Extra-Terminal (BET) proteins are a conserved family of ‘epigenetic readers’ that bind to acetylated lysine residues on histone and non-histone proteins to modulate… (more)

Subjects/Keywords: bromodomain; epigenetics; PD-L1; cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hogg, S. J. (2017). BET bromodomain inhibition as combined apoptotic and immunomodulatory therapy for the treatment of MYC-driven lymphoma. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/191790

Chicago Manual of Style (16th Edition):

Hogg, Simon John. “BET bromodomain inhibition as combined apoptotic and immunomodulatory therapy for the treatment of MYC-driven lymphoma.” 2017. Doctoral Dissertation, University of Melbourne. Accessed January 19, 2021. http://hdl.handle.net/11343/191790.

MLA Handbook (7th Edition):

Hogg, Simon John. “BET bromodomain inhibition as combined apoptotic and immunomodulatory therapy for the treatment of MYC-driven lymphoma.” 2017. Web. 19 Jan 2021.

Vancouver:

Hogg SJ. BET bromodomain inhibition as combined apoptotic and immunomodulatory therapy for the treatment of MYC-driven lymphoma. [Internet] [Doctoral dissertation]. University of Melbourne; 2017. [cited 2021 Jan 19]. Available from: http://hdl.handle.net/11343/191790.

Council of Science Editors:

Hogg SJ. BET bromodomain inhibition as combined apoptotic and immunomodulatory therapy for the treatment of MYC-driven lymphoma. [Doctoral Dissertation]. University of Melbourne; 2017. Available from: http://hdl.handle.net/11343/191790

4. 脇田, 晃行. REG Iα Promotes PD-L1 Expression in Esophageal Cancer Cells. : 食道扁平上皮癌細胞において REG Iαは PD-L1 の発現を誘導する.

Degree: 博士(医学), 2017, Akita University / 秋田大学

 Regenerating gene (REG)Iα is known to contribute to carcinogenesis and to be associated with a poor prognosis in various cancers. Programmed death-1 ligand(PD-L1) is a… (more)

Subjects/Keywords: PD-L1; REG Iα; esophageal cancer

Page 1 Page 2

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

脇田, . (2017). REG Iα Promotes PD-L1 Expression in Esophageal Cancer Cells. : 食道扁平上皮癌細胞において REG Iαは PD-L1 の発現を誘導する. (Thesis). Akita University / 秋田大学. Retrieved from http://hdl.handle.net/10295/2884

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

脇田, 晃行. “REG Iα Promotes PD-L1 Expression in Esophageal Cancer Cells. : 食道扁平上皮癌細胞において REG Iαは PD-L1 の発現を誘導する.” 2017. Thesis, Akita University / 秋田大学. Accessed January 19, 2021. http://hdl.handle.net/10295/2884.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

脇田, 晃行. “REG Iα Promotes PD-L1 Expression in Esophageal Cancer Cells. : 食道扁平上皮癌細胞において REG Iαは PD-L1 の発現を誘導する.” 2017. Web. 19 Jan 2021.

Vancouver:

脇田 . REG Iα Promotes PD-L1 Expression in Esophageal Cancer Cells. : 食道扁平上皮癌細胞において REG Iαは PD-L1 の発現を誘導する. [Internet] [Thesis]. Akita University / 秋田大学; 2017. [cited 2021 Jan 19]. Available from: http://hdl.handle.net/10295/2884.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

脇田 . REG Iα Promotes PD-L1 Expression in Esophageal Cancer Cells. : 食道扁平上皮癌細胞において REG Iαは PD-L1 の発現を誘導する. [Thesis]. Akita University / 秋田大学; 2017. Available from: http://hdl.handle.net/10295/2884

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Toronto

5. Nam, Junghyun. Investigating the Immune Microenvironment in Osteosarcomas.

Degree: 2017, University of Toronto

Osteosarcoma (OS) is a mesenchymal tumor that is the most common malignant bone tumor in children and young adults. Our objective was to identify novel… (more)

Subjects/Keywords: EIF2; microenvironment; osteosarcoma; PD-L1; 0307

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Nam, J. (2017). Investigating the Immune Microenvironment in Osteosarcomas. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/79276

Chicago Manual of Style (16th Edition):

Nam, Junghyun. “Investigating the Immune Microenvironment in Osteosarcomas.” 2017. Masters Thesis, University of Toronto. Accessed January 19, 2021. http://hdl.handle.net/1807/79276.

MLA Handbook (7th Edition):

Nam, Junghyun. “Investigating the Immune Microenvironment in Osteosarcomas.” 2017. Web. 19 Jan 2021.

Vancouver:

Nam J. Investigating the Immune Microenvironment in Osteosarcomas. [Internet] [Masters thesis]. University of Toronto; 2017. [cited 2021 Jan 19]. Available from: http://hdl.handle.net/1807/79276.

Council of Science Editors:

Nam J. Investigating the Immune Microenvironment in Osteosarcomas. [Masters Thesis]. University of Toronto; 2017. Available from: http://hdl.handle.net/1807/79276


University of Cambridge

6. Chen, Sofia Yixin. Genetic alterations defining human primary melanoma and mechanisms of immune evasion.

Degree: PhD, 2020, University of Cambridge

 The somatic mutations found in melanomas reflect the biological processes that govern tumour development. They also help shape how tumours evolve and escape immune regulation.… (more)

Subjects/Keywords: melanoma; genetic; alterations; immune; PD-L1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chen, S. Y. (2020). Genetic alterations defining human primary melanoma and mechanisms of immune evasion. (Doctoral Dissertation). University of Cambridge. Retrieved from https://www.repository.cam.ac.uk/handle/1810/304198https://www.repository.cam.ac.uk/bitstream/1810/304198/3/6b339e05-7c50-455c-89b1-85cf227a3364_confirmations.txt ; https://www.repository.cam.ac.uk/bitstream/1810/304198/4/license.txt ; https://www.repository.cam.ac.uk/bitstream/1810/304198/5/6b339e05-7c50-455c-89b1-85cf227a3364.zip

Chicago Manual of Style (16th Edition):

Chen, Sofia Yixin. “Genetic alterations defining human primary melanoma and mechanisms of immune evasion.” 2020. Doctoral Dissertation, University of Cambridge. Accessed January 19, 2021. https://www.repository.cam.ac.uk/handle/1810/304198https://www.repository.cam.ac.uk/bitstream/1810/304198/3/6b339e05-7c50-455c-89b1-85cf227a3364_confirmations.txt ; https://www.repository.cam.ac.uk/bitstream/1810/304198/4/license.txt ; https://www.repository.cam.ac.uk/bitstream/1810/304198/5/6b339e05-7c50-455c-89b1-85cf227a3364.zip.

MLA Handbook (7th Edition):

Chen, Sofia Yixin. “Genetic alterations defining human primary melanoma and mechanisms of immune evasion.” 2020. Web. 19 Jan 2021.

Vancouver:

Chen SY. Genetic alterations defining human primary melanoma and mechanisms of immune evasion. [Internet] [Doctoral dissertation]. University of Cambridge; 2020. [cited 2021 Jan 19]. Available from: https://www.repository.cam.ac.uk/handle/1810/304198https://www.repository.cam.ac.uk/bitstream/1810/304198/3/6b339e05-7c50-455c-89b1-85cf227a3364_confirmations.txt ; https://www.repository.cam.ac.uk/bitstream/1810/304198/4/license.txt ; https://www.repository.cam.ac.uk/bitstream/1810/304198/5/6b339e05-7c50-455c-89b1-85cf227a3364.zip.

Council of Science Editors:

Chen SY. Genetic alterations defining human primary melanoma and mechanisms of immune evasion. [Doctoral Dissertation]. University of Cambridge; 2020. Available from: https://www.repository.cam.ac.uk/handle/1810/304198https://www.repository.cam.ac.uk/bitstream/1810/304198/3/6b339e05-7c50-455c-89b1-85cf227a3364_confirmations.txt ; https://www.repository.cam.ac.uk/bitstream/1810/304198/4/license.txt ; https://www.repository.cam.ac.uk/bitstream/1810/304198/5/6b339e05-7c50-455c-89b1-85cf227a3364.zip


University of New South Wales

7. Voli, Florida. Tumour copper levels regulate PD-L1 driven immune evasion.

Degree: Children's Cancer Institute Australia for Medical Research, 2019, University of New South Wales

 Cancer immune evasion is recognised as a central hallmark of tumour development. One mechanism that cancer cells use to protect themselves from anti-tumour immune responses… (more)

Subjects/Keywords: PD-L1; Copper; Immune evasion; Cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Voli, F. (2019). Tumour copper levels regulate PD-L1 driven immune evasion. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/64905

Chicago Manual of Style (16th Edition):

Voli, Florida. “Tumour copper levels regulate PD-L1 driven immune evasion.” 2019. Doctoral Dissertation, University of New South Wales. Accessed January 19, 2021. http://handle.unsw.edu.au/1959.4/64905.

MLA Handbook (7th Edition):

Voli, Florida. “Tumour copper levels regulate PD-L1 driven immune evasion.” 2019. Web. 19 Jan 2021.

Vancouver:

Voli F. Tumour copper levels regulate PD-L1 driven immune evasion. [Internet] [Doctoral dissertation]. University of New South Wales; 2019. [cited 2021 Jan 19]. Available from: http://handle.unsw.edu.au/1959.4/64905.

Council of Science Editors:

Voli F. Tumour copper levels regulate PD-L1 driven immune evasion. [Doctoral Dissertation]. University of New South Wales; 2019. Available from: http://handle.unsw.edu.au/1959.4/64905


University of New South Wales

8. Wang, Yiming. Investigation of GS1 and GS2 C. concisus adaptation in the human gastrointestinal tract and their effects on PD-L1 expression in human intestinal epithelial cells.

Degree: Biotechnology & Biomolecular Sciences, 2018, University of New South Wales

 Campylobacter concisusis a Gram-negative bacterium with a singular polar flagellum and curved morphology that enables it to traverse the mucus layer and directly contact the… (more)

Subjects/Keywords: PD-L1; Campylobacter concisus; Inflammatory bowel disease

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wang, Y. (2018). Investigation of GS1 and GS2 C. concisus adaptation in the human gastrointestinal tract and their effects on PD-L1 expression in human intestinal epithelial cells. (Masters Thesis). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/60214 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:51079/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Wang, Yiming. “Investigation of GS1 and GS2 C. concisus adaptation in the human gastrointestinal tract and their effects on PD-L1 expression in human intestinal epithelial cells.” 2018. Masters Thesis, University of New South Wales. Accessed January 19, 2021. http://handle.unsw.edu.au/1959.4/60214 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:51079/SOURCE02?view=true.

MLA Handbook (7th Edition):

Wang, Yiming. “Investigation of GS1 and GS2 C. concisus adaptation in the human gastrointestinal tract and their effects on PD-L1 expression in human intestinal epithelial cells.” 2018. Web. 19 Jan 2021.

Vancouver:

Wang Y. Investigation of GS1 and GS2 C. concisus adaptation in the human gastrointestinal tract and their effects on PD-L1 expression in human intestinal epithelial cells. [Internet] [Masters thesis]. University of New South Wales; 2018. [cited 2021 Jan 19]. Available from: http://handle.unsw.edu.au/1959.4/60214 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:51079/SOURCE02?view=true.

Council of Science Editors:

Wang Y. Investigation of GS1 and GS2 C. concisus adaptation in the human gastrointestinal tract and their effects on PD-L1 expression in human intestinal epithelial cells. [Masters Thesis]. University of New South Wales; 2018. Available from: http://handle.unsw.edu.au/1959.4/60214 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:51079/SOURCE02?view=true


University of Vienna

9. Plangger, Adelina Sophia. Lung cancer: chemosensitivity and PD-L1 expression of primary non-small cell lung (NSCLC) cancer cell lines.

Degree: 2019, University of Vienna

 Der nicht-kleinzellige Lungenkrebs (NSCLC) macht zirka 85% der Lungenkrebsarten aus. Die klassische Therapiemöglichkeit zur Behandlung von Lungenkrebs besteht aus platinbasierten Medikamenten (Cisplatin oder Carboplatin) in… (more)

Subjects/Keywords: 42.13 Molekularbiologie; Lungenkrebs / Chemoresistenz / Cisplatin / PD-L1; Lung cancer / chemoresistance / cisplatin / PD-L1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Plangger, A. S. (2019). Lung cancer: chemosensitivity and PD-L1 expression of primary non-small cell lung (NSCLC) cancer cell lines. (Thesis). University of Vienna. Retrieved from http://othes.univie.ac.at/60284/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Plangger, Adelina Sophia. “Lung cancer: chemosensitivity and PD-L1 expression of primary non-small cell lung (NSCLC) cancer cell lines.” 2019. Thesis, University of Vienna. Accessed January 19, 2021. http://othes.univie.ac.at/60284/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Plangger, Adelina Sophia. “Lung cancer: chemosensitivity and PD-L1 expression of primary non-small cell lung (NSCLC) cancer cell lines.” 2019. Web. 19 Jan 2021.

Vancouver:

Plangger AS. Lung cancer: chemosensitivity and PD-L1 expression of primary non-small cell lung (NSCLC) cancer cell lines. [Internet] [Thesis]. University of Vienna; 2019. [cited 2021 Jan 19]. Available from: http://othes.univie.ac.at/60284/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Plangger AS. Lung cancer: chemosensitivity and PD-L1 expression of primary non-small cell lung (NSCLC) cancer cell lines. [Thesis]. University of Vienna; 2019. Available from: http://othes.univie.ac.at/60284/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

10. Yazbeck, Nathalie. Contrôle de l’immunité antitumorale par la signalisation de SQSTM1 : Control of antitumor immunity by the SQSTM1 dependent signaling.

Degree: Docteur es, Interractions moléculaires et cellulaires, 2018, Université Côte d'Azur (ComUE)

La dernière décennie a connu une révolution dans le traitement du cancer en s'éloignant des médicaments conventionnels qui ciblent directement la tumeur (comme les chimiothérapies… (more)

Subjects/Keywords: Immunothérapies; PD1/PD‐L1; Biomarqueurs; Sequestosome 1; Immunotherapies; PD1/PD‐L1; Biomarker; Sequestosome 1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yazbeck, N. (2018). Contrôle de l’immunité antitumorale par la signalisation de SQSTM1 : Control of antitumor immunity by the SQSTM1 dependent signaling. (Doctoral Dissertation). Université Côte d'Azur (ComUE). Retrieved from http://www.theses.fr/2018AZUR4072

Chicago Manual of Style (16th Edition):

Yazbeck, Nathalie. “Contrôle de l’immunité antitumorale par la signalisation de SQSTM1 : Control of antitumor immunity by the SQSTM1 dependent signaling.” 2018. Doctoral Dissertation, Université Côte d'Azur (ComUE). Accessed January 19, 2021. http://www.theses.fr/2018AZUR4072.

MLA Handbook (7th Edition):

Yazbeck, Nathalie. “Contrôle de l’immunité antitumorale par la signalisation de SQSTM1 : Control of antitumor immunity by the SQSTM1 dependent signaling.” 2018. Web. 19 Jan 2021.

Vancouver:

Yazbeck N. Contrôle de l’immunité antitumorale par la signalisation de SQSTM1 : Control of antitumor immunity by the SQSTM1 dependent signaling. [Internet] [Doctoral dissertation]. Université Côte d'Azur (ComUE); 2018. [cited 2021 Jan 19]. Available from: http://www.theses.fr/2018AZUR4072.

Council of Science Editors:

Yazbeck N. Contrôle de l’immunité antitumorale par la signalisation de SQSTM1 : Control of antitumor immunity by the SQSTM1 dependent signaling. [Doctoral Dissertation]. Université Côte d'Azur (ComUE); 2018. Available from: http://www.theses.fr/2018AZUR4072


Harvard University

11. Talat, Hammad. Combination Immunotherapy for Glioblastoma Multiforme With the Combination of GVAX and PD-1 Blockade, Using Anti-PD1 Antibody.

Degree: ALM, 2018, Harvard University

Glioblastoma Multiforme (GBM), also known as grade IV astrocytoma, is generally found in the cerebral hemispheres but can be found anywhere else in the brain… (more)

Subjects/Keywords: Glioma; Immunotherapy; GVAX; PD-1; PD-L1; OX-40; Glioblastoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Talat, H. (2018). Combination Immunotherapy for Glioblastoma Multiforme With the Combination of GVAX and PD-1 Blockade, Using Anti-PD1 Antibody. (Masters Thesis). Harvard University. Retrieved from http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004052

Chicago Manual of Style (16th Edition):

Talat, Hammad. “Combination Immunotherapy for Glioblastoma Multiforme With the Combination of GVAX and PD-1 Blockade, Using Anti-PD1 Antibody.” 2018. Masters Thesis, Harvard University. Accessed January 19, 2021. http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004052.

MLA Handbook (7th Edition):

Talat, Hammad. “Combination Immunotherapy for Glioblastoma Multiforme With the Combination of GVAX and PD-1 Blockade, Using Anti-PD1 Antibody.” 2018. Web. 19 Jan 2021.

Vancouver:

Talat H. Combination Immunotherapy for Glioblastoma Multiforme With the Combination of GVAX and PD-1 Blockade, Using Anti-PD1 Antibody. [Internet] [Masters thesis]. Harvard University; 2018. [cited 2021 Jan 19]. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004052.

Council of Science Editors:

Talat H. Combination Immunotherapy for Glioblastoma Multiforme With the Combination of GVAX and PD-1 Blockade, Using Anti-PD1 Antibody. [Masters Thesis]. Harvard University; 2018. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004052

12. Fournel, Ludovic. Influence Du Cisplatine sur l'expression du Check-Point Immunitaire PD-1/PD-L1 Dans Le Cancer Broncho-Pulmonaire Non A Petites Cellules : impact of Cisplatin on the Expression of Immune Check-Point PD-1/PD-L1 in Non Small Cell Lung Carcinoma.

Degree: Docteur es, Sciences de la vie et de la santé, 2020, université Paris-Saclay

Malgré les nombreux progrés réalisés ces dernières années dans la prise en charge thérapeutique du cancer broncho-pulmonaire, cette pathologie reste la première cause de décès… (more)

Subjects/Keywords: Carcinome broncho-Pulmonaire; Pd1/pd-L1; Immunothérapie; Cisplatine; Neurotensine; Lung carcinoma; Pd-1/pd-L1; Immune therapy; Cisplatin; Neurotensin

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fournel, L. (2020). Influence Du Cisplatine sur l'expression du Check-Point Immunitaire PD-1/PD-L1 Dans Le Cancer Broncho-Pulmonaire Non A Petites Cellules : impact of Cisplatin on the Expression of Immune Check-Point PD-1/PD-L1 in Non Small Cell Lung Carcinoma. (Doctoral Dissertation). université Paris-Saclay. Retrieved from http://www.theses.fr/2020UPASS077

Chicago Manual of Style (16th Edition):

Fournel, Ludovic. “Influence Du Cisplatine sur l'expression du Check-Point Immunitaire PD-1/PD-L1 Dans Le Cancer Broncho-Pulmonaire Non A Petites Cellules : impact of Cisplatin on the Expression of Immune Check-Point PD-1/PD-L1 in Non Small Cell Lung Carcinoma.” 2020. Doctoral Dissertation, université Paris-Saclay. Accessed January 19, 2021. http://www.theses.fr/2020UPASS077.

MLA Handbook (7th Edition):

Fournel, Ludovic. “Influence Du Cisplatine sur l'expression du Check-Point Immunitaire PD-1/PD-L1 Dans Le Cancer Broncho-Pulmonaire Non A Petites Cellules : impact of Cisplatin on the Expression of Immune Check-Point PD-1/PD-L1 in Non Small Cell Lung Carcinoma.” 2020. Web. 19 Jan 2021.

Vancouver:

Fournel L. Influence Du Cisplatine sur l'expression du Check-Point Immunitaire PD-1/PD-L1 Dans Le Cancer Broncho-Pulmonaire Non A Petites Cellules : impact of Cisplatin on the Expression of Immune Check-Point PD-1/PD-L1 in Non Small Cell Lung Carcinoma. [Internet] [Doctoral dissertation]. université Paris-Saclay; 2020. [cited 2021 Jan 19]. Available from: http://www.theses.fr/2020UPASS077.

Council of Science Editors:

Fournel L. Influence Du Cisplatine sur l'expression du Check-Point Immunitaire PD-1/PD-L1 Dans Le Cancer Broncho-Pulmonaire Non A Petites Cellules : impact of Cisplatin on the Expression of Immune Check-Point PD-1/PD-L1 in Non Small Cell Lung Carcinoma. [Doctoral Dissertation]. université Paris-Saclay; 2020. Available from: http://www.theses.fr/2020UPASS077


Karlstad University

13. Härdin, Jonas. Cutibacterium acnes inverkan på makrofagers produktion av PD-L1.

Degree: Environmental and Life Sciences (from 2013), 2020, Karlstad University

Prostatacancer är den vanligaste cancerformen hos män i Sverige, och det är även den cancerform som flest män dör utav. Detta till trots så… (more)

Subjects/Keywords: Macrophages; PD-L1; prostate cancer; Cutibacterium acnes; C. acnes; Makrofager; PD-L1; prostatacancer; Cutibacterium acnes; C. acnes; Immunology; Immunologi

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Härdin, J. (2020). Cutibacterium acnes inverkan på makrofagers produktion av PD-L1. (Thesis). Karlstad University. Retrieved from http://urn.kb.se/resolve?urn=urn:nbn:se:kau:diva-78770

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Härdin, Jonas. “Cutibacterium acnes inverkan på makrofagers produktion av PD-L1.” 2020. Thesis, Karlstad University. Accessed January 19, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:kau:diva-78770.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Härdin, Jonas. “Cutibacterium acnes inverkan på makrofagers produktion av PD-L1.” 2020. Web. 19 Jan 2021.

Vancouver:

Härdin J. Cutibacterium acnes inverkan på makrofagers produktion av PD-L1. [Internet] [Thesis]. Karlstad University; 2020. [cited 2021 Jan 19]. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:kau:diva-78770.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Härdin J. Cutibacterium acnes inverkan på makrofagers produktion av PD-L1. [Thesis]. Karlstad University; 2020. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:kau:diva-78770

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

14. D'Almeida, Sénan. Rôle de l’éctonucléotidase CD39 dans l’acquisition d’un phénotype immunorégulateur par les macrophages associés aux tumeurs : The ectonucleotidase CD39 in the acquisition of an immunosuppressive phenotype by tumor-associated macrophages.

Degree: Docteur es, Aspects moléculaires et cellulaires de la biologie, 2015, Angers

Les macrophages associés aux tumeurs (TAM) sont des cellules immunorégulatrices qui s’accumulent massivement dans le microenvironnement (ME) tumoral. Chez les patients atteints de cancer de… (more)

Subjects/Keywords: NTPDase1 CD39; Immunorégulation; Points de contrôles immunologiques (PD-L1); NTPDase1 CD39; Immunoregulation; Immune checkpoint (PD-L1); 610

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

D'Almeida, S. (2015). Rôle de l’éctonucléotidase CD39 dans l’acquisition d’un phénotype immunorégulateur par les macrophages associés aux tumeurs : The ectonucleotidase CD39 in the acquisition of an immunosuppressive phenotype by tumor-associated macrophages. (Doctoral Dissertation). Angers. Retrieved from http://www.theses.fr/2015ANGE0006

Chicago Manual of Style (16th Edition):

D'Almeida, Sénan. “Rôle de l’éctonucléotidase CD39 dans l’acquisition d’un phénotype immunorégulateur par les macrophages associés aux tumeurs : The ectonucleotidase CD39 in the acquisition of an immunosuppressive phenotype by tumor-associated macrophages.” 2015. Doctoral Dissertation, Angers. Accessed January 19, 2021. http://www.theses.fr/2015ANGE0006.

MLA Handbook (7th Edition):

D'Almeida, Sénan. “Rôle de l’éctonucléotidase CD39 dans l’acquisition d’un phénotype immunorégulateur par les macrophages associés aux tumeurs : The ectonucleotidase CD39 in the acquisition of an immunosuppressive phenotype by tumor-associated macrophages.” 2015. Web. 19 Jan 2021.

Vancouver:

D'Almeida S. Rôle de l’éctonucléotidase CD39 dans l’acquisition d’un phénotype immunorégulateur par les macrophages associés aux tumeurs : The ectonucleotidase CD39 in the acquisition of an immunosuppressive phenotype by tumor-associated macrophages. [Internet] [Doctoral dissertation]. Angers; 2015. [cited 2021 Jan 19]. Available from: http://www.theses.fr/2015ANGE0006.

Council of Science Editors:

D'Almeida S. Rôle de l’éctonucléotidase CD39 dans l’acquisition d’un phénotype immunorégulateur par les macrophages associés aux tumeurs : The ectonucleotidase CD39 in the acquisition of an immunosuppressive phenotype by tumor-associated macrophages. [Doctoral Dissertation]. Angers; 2015. Available from: http://www.theses.fr/2015ANGE0006

15. Lereclus, Emilie. Origine et rôles des cellules myéloïdes suppressives dans le sepsis : Origin and roles of myeloid-derived suppressor cells during sepsis.

Degree: Docteur es, Immunologie, oncologie et infectiologie, 2018, Limoges

Les Myeloid-Derived Suppressor Cells (MDSC) sont une population hétérogène de cellules myéloïdes immatures, regroupées en deux sous-populations : les monocytiques-MDSC (M-MDSC) et les polymorphonucléaires-MDSC (PMN-MDSC).… (more)

Subjects/Keywords: MDSC; Sepsis; Moelle osseuse; PD-L1; Cytokines; TTV; MDSC; Sepsis; Bone marrow; PD-L1; Cytokines; TTV; 615.37

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lereclus, E. (2018). Origine et rôles des cellules myéloïdes suppressives dans le sepsis : Origin and roles of myeloid-derived suppressor cells during sepsis. (Doctoral Dissertation). Limoges. Retrieved from http://www.theses.fr/2018LIMO0060

Chicago Manual of Style (16th Edition):

Lereclus, Emilie. “Origine et rôles des cellules myéloïdes suppressives dans le sepsis : Origin and roles of myeloid-derived suppressor cells during sepsis.” 2018. Doctoral Dissertation, Limoges. Accessed January 19, 2021. http://www.theses.fr/2018LIMO0060.

MLA Handbook (7th Edition):

Lereclus, Emilie. “Origine et rôles des cellules myéloïdes suppressives dans le sepsis : Origin and roles of myeloid-derived suppressor cells during sepsis.” 2018. Web. 19 Jan 2021.

Vancouver:

Lereclus E. Origine et rôles des cellules myéloïdes suppressives dans le sepsis : Origin and roles of myeloid-derived suppressor cells during sepsis. [Internet] [Doctoral dissertation]. Limoges; 2018. [cited 2021 Jan 19]. Available from: http://www.theses.fr/2018LIMO0060.

Council of Science Editors:

Lereclus E. Origine et rôles des cellules myéloïdes suppressives dans le sepsis : Origin and roles of myeloid-derived suppressor cells during sepsis. [Doctoral Dissertation]. Limoges; 2018. Available from: http://www.theses.fr/2018LIMO0060

16. Simard, François. Implication of immune system in chondrosarcoma progression and therapeutic response : Could immunotherapy play a role in chondrosarcoma treatment ? : L’implication du système immunitaire dans la progression et la réponse thérapeutique du chondrosarcome : Est-ce que l’immunothérapie peut jouer un rôle dans le traitement du chondrosarcome ?.

Degree: Docteur es, Biologie, 2016, Lyon

Le chondrosarcome (CHS) est caractérisé par une grande chimio et radiorésistance ; il y a un besoin urgent de nouvelles stratégies thérapeutiques pour cette tumeur.… (more)

Subjects/Keywords: Chondrosarcome; Lymphocyte; PD-1; PD-L1; Macrophage; Immunothérapie; PI3K/Akt/mTOR; Immunosurveillance; Chondrosarcoma; Lymphocyte; PD-1; PD-L1; Macrophages; Immunotherapy; PI3K/Akt/mTOR; Immunosurveillance; 571.96

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Simard, F. (2016). Implication of immune system in chondrosarcoma progression and therapeutic response : Could immunotherapy play a role in chondrosarcoma treatment ? : L’implication du système immunitaire dans la progression et la réponse thérapeutique du chondrosarcome : Est-ce que l’immunothérapie peut jouer un rôle dans le traitement du chondrosarcome ?. (Doctoral Dissertation). Lyon. Retrieved from http://www.theses.fr/2016LYSE1073

Chicago Manual of Style (16th Edition):

Simard, François. “Implication of immune system in chondrosarcoma progression and therapeutic response : Could immunotherapy play a role in chondrosarcoma treatment ? : L’implication du système immunitaire dans la progression et la réponse thérapeutique du chondrosarcome : Est-ce que l’immunothérapie peut jouer un rôle dans le traitement du chondrosarcome ?.” 2016. Doctoral Dissertation, Lyon. Accessed January 19, 2021. http://www.theses.fr/2016LYSE1073.

MLA Handbook (7th Edition):

Simard, François. “Implication of immune system in chondrosarcoma progression and therapeutic response : Could immunotherapy play a role in chondrosarcoma treatment ? : L’implication du système immunitaire dans la progression et la réponse thérapeutique du chondrosarcome : Est-ce que l’immunothérapie peut jouer un rôle dans le traitement du chondrosarcome ?.” 2016. Web. 19 Jan 2021.

Vancouver:

Simard F. Implication of immune system in chondrosarcoma progression and therapeutic response : Could immunotherapy play a role in chondrosarcoma treatment ? : L’implication du système immunitaire dans la progression et la réponse thérapeutique du chondrosarcome : Est-ce que l’immunothérapie peut jouer un rôle dans le traitement du chondrosarcome ?. [Internet] [Doctoral dissertation]. Lyon; 2016. [cited 2021 Jan 19]. Available from: http://www.theses.fr/2016LYSE1073.

Council of Science Editors:

Simard F. Implication of immune system in chondrosarcoma progression and therapeutic response : Could immunotherapy play a role in chondrosarcoma treatment ? : L’implication du système immunitaire dans la progression et la réponse thérapeutique du chondrosarcome : Est-ce que l’immunothérapie peut jouer un rôle dans le traitement du chondrosarcome ?. [Doctoral Dissertation]. Lyon; 2016. Available from: http://www.theses.fr/2016LYSE1073

17. Khou, Sokchea. Contribution des neutrophiles infiltrant les tumeurs dans la progression des carcinomes épidermoïdes cutanés : neutrophiles et cancer : Contribution of tumor-associated neutrophils in the course of cutaneous squamous cell carcinoma : neutrophils and cancer.

Degree: Docteur es, Interactions moléculaires et cellulaires, 2019, Université Côte d'Azur (ComUE)

 Les carcinomes cutanés constituent les cancers les plus fréquents chez l’homme et leur incidence est en constante croissance. Il en existe deux principaux types :… (more)

Subjects/Keywords: Carcinomes cutanés; Neutrophiles; Protumoral; Immunosuppression; PD-L1; PD-1; Transcriptome; Cutaneous squamous cell carcinomas; Neutrophils; Protumoral; Immunosuppression; PD-L1; PD-1; Transcriptomic analysis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Khou, S. (2019). Contribution des neutrophiles infiltrant les tumeurs dans la progression des carcinomes épidermoïdes cutanés : neutrophiles et cancer : Contribution of tumor-associated neutrophils in the course of cutaneous squamous cell carcinoma : neutrophils and cancer. (Doctoral Dissertation). Université Côte d'Azur (ComUE). Retrieved from http://www.theses.fr/2019AZUR4014

Chicago Manual of Style (16th Edition):

Khou, Sokchea. “Contribution des neutrophiles infiltrant les tumeurs dans la progression des carcinomes épidermoïdes cutanés : neutrophiles et cancer : Contribution of tumor-associated neutrophils in the course of cutaneous squamous cell carcinoma : neutrophils and cancer.” 2019. Doctoral Dissertation, Université Côte d'Azur (ComUE). Accessed January 19, 2021. http://www.theses.fr/2019AZUR4014.

MLA Handbook (7th Edition):

Khou, Sokchea. “Contribution des neutrophiles infiltrant les tumeurs dans la progression des carcinomes épidermoïdes cutanés : neutrophiles et cancer : Contribution of tumor-associated neutrophils in the course of cutaneous squamous cell carcinoma : neutrophils and cancer.” 2019. Web. 19 Jan 2021.

Vancouver:

Khou S. Contribution des neutrophiles infiltrant les tumeurs dans la progression des carcinomes épidermoïdes cutanés : neutrophiles et cancer : Contribution of tumor-associated neutrophils in the course of cutaneous squamous cell carcinoma : neutrophils and cancer. [Internet] [Doctoral dissertation]. Université Côte d'Azur (ComUE); 2019. [cited 2021 Jan 19]. Available from: http://www.theses.fr/2019AZUR4014.

Council of Science Editors:

Khou S. Contribution des neutrophiles infiltrant les tumeurs dans la progression des carcinomes épidermoïdes cutanés : neutrophiles et cancer : Contribution of tumor-associated neutrophils in the course of cutaneous squamous cell carcinoma : neutrophils and cancer. [Doctoral Dissertation]. Université Côte d'Azur (ComUE); 2019. Available from: http://www.theses.fr/2019AZUR4014

18. Kostine, Marie. Defining the immune microenvironment in sarcoma : could immunotherapy be part of the treatment strategy in sarcoma patients ? : Etude du microenvironnement immunitaire dans les sarcomes : pourrait-il y avoir une place pour l'immunothérapie dans la stratégie thérapeutique ?.

Degree: Docteur es, Biologie Cellulaire et Physiopathologie, 2018, Bordeaux

La chirurgie est la pierre angulaire du traitement curatif des sarcomes, lorsqu’elle est possible. En revanche, en cas de maladie avancée ou métastatique, les traitements… (more)

Subjects/Keywords: Sarcome; Immunothérapie; Pd-1/pd-L1; Hla; Macrophages associés aux tumeurs; Lymphocytes T; Sarcoma; Immunotherapy; Pd-1/pd-L1; Hla; Tumor-Associated macrophages; T cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kostine, M. (2018). Defining the immune microenvironment in sarcoma : could immunotherapy be part of the treatment strategy in sarcoma patients ? : Etude du microenvironnement immunitaire dans les sarcomes : pourrait-il y avoir une place pour l'immunothérapie dans la stratégie thérapeutique ?. (Doctoral Dissertation). Bordeaux. Retrieved from http://www.theses.fr/2018BORD0387

Chicago Manual of Style (16th Edition):

Kostine, Marie. “Defining the immune microenvironment in sarcoma : could immunotherapy be part of the treatment strategy in sarcoma patients ? : Etude du microenvironnement immunitaire dans les sarcomes : pourrait-il y avoir une place pour l'immunothérapie dans la stratégie thérapeutique ?.” 2018. Doctoral Dissertation, Bordeaux. Accessed January 19, 2021. http://www.theses.fr/2018BORD0387.

MLA Handbook (7th Edition):

Kostine, Marie. “Defining the immune microenvironment in sarcoma : could immunotherapy be part of the treatment strategy in sarcoma patients ? : Etude du microenvironnement immunitaire dans les sarcomes : pourrait-il y avoir une place pour l'immunothérapie dans la stratégie thérapeutique ?.” 2018. Web. 19 Jan 2021.

Vancouver:

Kostine M. Defining the immune microenvironment in sarcoma : could immunotherapy be part of the treatment strategy in sarcoma patients ? : Etude du microenvironnement immunitaire dans les sarcomes : pourrait-il y avoir une place pour l'immunothérapie dans la stratégie thérapeutique ?. [Internet] [Doctoral dissertation]. Bordeaux; 2018. [cited 2021 Jan 19]. Available from: http://www.theses.fr/2018BORD0387.

Council of Science Editors:

Kostine M. Defining the immune microenvironment in sarcoma : could immunotherapy be part of the treatment strategy in sarcoma patients ? : Etude du microenvironnement immunitaire dans les sarcomes : pourrait-il y avoir une place pour l'immunothérapie dans la stratégie thérapeutique ?. [Doctoral Dissertation]. Bordeaux; 2018. Available from: http://www.theses.fr/2018BORD0387

19. Inoue, Yusuke. Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義.

Degree: 博士(医学), 2017, Hamamatsu University School of Medicine / 浜松医科大学

New reliable biomarkers are needed to predict the response to immune checkpoint inhibitors against programmed death‑1 (PD‑1) and its ligand (PD‑L1), because PD‑L1 expression on… (more)

Subjects/Keywords: PD‑L1; PD‑L2; amplification; copy number; non‑small‑cell lung cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Inoue, Y. (2017). Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義. (Thesis). Hamamatsu University School of Medicine / 浜松医科大学. Retrieved from http://hdl.handle.net/10271/3219

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Inoue, Yusuke. “Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義.” 2017. Thesis, Hamamatsu University School of Medicine / 浜松医科大学. Accessed January 19, 2021. http://hdl.handle.net/10271/3219.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Inoue, Yusuke. “Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義.” 2017. Web. 19 Jan 2021.

Vancouver:

Inoue Y. Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義. [Internet] [Thesis]. Hamamatsu University School of Medicine / 浜松医科大学; 2017. [cited 2021 Jan 19]. Available from: http://hdl.handle.net/10271/3219.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Inoue Y. Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義. [Thesis]. Hamamatsu University School of Medicine / 浜松医科大学; 2017. Available from: http://hdl.handle.net/10271/3219

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


East Carolina University

20. Atwell, Druid Carlisle. Identification of Biomarkers in Non-Small Cell Lung Cancer Patients Treated with PD-1 Monoclonal Antibody Immunotherapy.

Degree: MS, MS-Biomedical Science, 2018, East Carolina University

 Cancer immunotherapy works by taking a patient's existing immune system and priming it to recognize cancer cells in order for immune cells to mount an… (more)

Subjects/Keywords: PD-1; PD-L1; Antibodies, Monoclonal; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Immunotherapy; Humans

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Atwell, D. C. (2018). Identification of Biomarkers in Non-Small Cell Lung Cancer Patients Treated with PD-1 Monoclonal Antibody Immunotherapy. (Masters Thesis). East Carolina University. Retrieved from http://hdl.handle.net/10342/7016

Chicago Manual of Style (16th Edition):

Atwell, Druid Carlisle. “Identification of Biomarkers in Non-Small Cell Lung Cancer Patients Treated with PD-1 Monoclonal Antibody Immunotherapy.” 2018. Masters Thesis, East Carolina University. Accessed January 19, 2021. http://hdl.handle.net/10342/7016.

MLA Handbook (7th Edition):

Atwell, Druid Carlisle. “Identification of Biomarkers in Non-Small Cell Lung Cancer Patients Treated with PD-1 Monoclonal Antibody Immunotherapy.” 2018. Web. 19 Jan 2021.

Vancouver:

Atwell DC. Identification of Biomarkers in Non-Small Cell Lung Cancer Patients Treated with PD-1 Monoclonal Antibody Immunotherapy. [Internet] [Masters thesis]. East Carolina University; 2018. [cited 2021 Jan 19]. Available from: http://hdl.handle.net/10342/7016.

Council of Science Editors:

Atwell DC. Identification of Biomarkers in Non-Small Cell Lung Cancer Patients Treated with PD-1 Monoclonal Antibody Immunotherapy. [Masters Thesis]. East Carolina University; 2018. Available from: http://hdl.handle.net/10342/7016


University of Toronto

21. Lee, Minji. Investigating Molecular Differences related to T-bet-Positive Tumor-infiltrating Lymphocytes in Axillary Node-negative Breast Cancer.

Degree: 2017, University of Toronto

The clinical outcomes of axillary node-negative (ANN) breast cancer (BC) patients were previously shown to be positively associated with T-bet+ tumor-infiltrating lymphocytes (TILs). This study… (more)

Subjects/Keywords: BRD4; Breast Cancer; miRNA; PD-L1; T-bet; TIL; 0307

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lee, M. (2017). Investigating Molecular Differences related to T-bet-Positive Tumor-infiltrating Lymphocytes in Axillary Node-negative Breast Cancer. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/77837

Chicago Manual of Style (16th Edition):

Lee, Minji. “Investigating Molecular Differences related to T-bet-Positive Tumor-infiltrating Lymphocytes in Axillary Node-negative Breast Cancer.” 2017. Masters Thesis, University of Toronto. Accessed January 19, 2021. http://hdl.handle.net/1807/77837.

MLA Handbook (7th Edition):

Lee, Minji. “Investigating Molecular Differences related to T-bet-Positive Tumor-infiltrating Lymphocytes in Axillary Node-negative Breast Cancer.” 2017. Web. 19 Jan 2021.

Vancouver:

Lee M. Investigating Molecular Differences related to T-bet-Positive Tumor-infiltrating Lymphocytes in Axillary Node-negative Breast Cancer. [Internet] [Masters thesis]. University of Toronto; 2017. [cited 2021 Jan 19]. Available from: http://hdl.handle.net/1807/77837.

Council of Science Editors:

Lee M. Investigating Molecular Differences related to T-bet-Positive Tumor-infiltrating Lymphocytes in Axillary Node-negative Breast Cancer. [Masters Thesis]. University of Toronto; 2017. Available from: http://hdl.handle.net/1807/77837


University of Southern California

22. Usher, Joshua. Use of cell-free nucleic acids in associating PD-L1 gene expression with presence of driver mutations in DNA and demographics across different cancers.

Degree: MS, Biostatistics, 2016, University of Southern California

 Introduction: Measuring allele frequencies of somatic gene mutations in DNA and levels of relative gene expressions in RNA can now be measured using cell-free nucleic… (more)

Subjects/Keywords: PD-L1; BRAF; KRAS; EGFR; cell-free; DNA; RNA

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Usher, J. (2016). Use of cell-free nucleic acids in associating PD-L1 gene expression with presence of driver mutations in DNA and demographics across different cancers. (Masters Thesis). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/640124/rec/7732

Chicago Manual of Style (16th Edition):

Usher, Joshua. “Use of cell-free nucleic acids in associating PD-L1 gene expression with presence of driver mutations in DNA and demographics across different cancers.” 2016. Masters Thesis, University of Southern California. Accessed January 19, 2021. http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/640124/rec/7732.

MLA Handbook (7th Edition):

Usher, Joshua. “Use of cell-free nucleic acids in associating PD-L1 gene expression with presence of driver mutations in DNA and demographics across different cancers.” 2016. Web. 19 Jan 2021.

Vancouver:

Usher J. Use of cell-free nucleic acids in associating PD-L1 gene expression with presence of driver mutations in DNA and demographics across different cancers. [Internet] [Masters thesis]. University of Southern California; 2016. [cited 2021 Jan 19]. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/640124/rec/7732.

Council of Science Editors:

Usher J. Use of cell-free nucleic acids in associating PD-L1 gene expression with presence of driver mutations in DNA and demographics across different cancers. [Masters Thesis]. University of Southern California; 2016. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/640124/rec/7732


University of Sydney

23. Williams, Marissa. Aberrant MicroRNA Expression in Malignant Pleural Mesothelioma .

Degree: 2018, University of Sydney

 Malignant Pleural Mesothelioma (MPM) is an aggressive asbestos related malignancy. The global downregulation of microRNA (miRNA) expression is common in MPM, however, the mechanisms driving… (more)

Subjects/Keywords: mesothelioma; microRNA; c-Myc; drug resistance; PD-L1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Williams, M. (2018). Aberrant MicroRNA Expression in Malignant Pleural Mesothelioma . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/19754

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Williams, Marissa. “Aberrant MicroRNA Expression in Malignant Pleural Mesothelioma .” 2018. Thesis, University of Sydney. Accessed January 19, 2021. http://hdl.handle.net/2123/19754.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Williams, Marissa. “Aberrant MicroRNA Expression in Malignant Pleural Mesothelioma .” 2018. Web. 19 Jan 2021.

Vancouver:

Williams M. Aberrant MicroRNA Expression in Malignant Pleural Mesothelioma . [Internet] [Thesis]. University of Sydney; 2018. [cited 2021 Jan 19]. Available from: http://hdl.handle.net/2123/19754.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Williams M. Aberrant MicroRNA Expression in Malignant Pleural Mesothelioma . [Thesis]. University of Sydney; 2018. Available from: http://hdl.handle.net/2123/19754

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Otago

24. Ahn, Jeong Hyun (Antonio). Constitutive PD-L1 expression in melanoma .

Degree: University of Otago

 Treatment of melanoma based on targeted therapy and immunotherapy has dramatically advanced over the past decade. Advances in targeted therapy have been based on inhibition… (more)

Subjects/Keywords: Melanoma; PD-L1; Constitutive

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ahn, J. H. (. (n.d.). Constitutive PD-L1 expression in melanoma . (Doctoral Dissertation). University of Otago. Retrieved from http://hdl.handle.net/10523/10079

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Chicago Manual of Style (16th Edition):

Ahn, Jeong Hyun (Antonio). “Constitutive PD-L1 expression in melanoma .” Doctoral Dissertation, University of Otago. Accessed January 19, 2021. http://hdl.handle.net/10523/10079.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

MLA Handbook (7th Edition):

Ahn, Jeong Hyun (Antonio). “Constitutive PD-L1 expression in melanoma .” Web. 19 Jan 2021.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Ahn JH(. Constitutive PD-L1 expression in melanoma . [Internet] [Doctoral dissertation]. University of Otago; [cited 2021 Jan 19]. Available from: http://hdl.handle.net/10523/10079.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Council of Science Editors:

Ahn JH(. Constitutive PD-L1 expression in melanoma . [Doctoral Dissertation]. University of Otago; Available from: http://hdl.handle.net/10523/10079

Note: this citation may be lacking information needed for this citation format:
No year of publication.

25. Auclair, Héloïse. Etude des homologies phénotypiques et fonctionnelles des lymphocytes B en latence III de l'EBV avec les cellules B régulatrices, implication de l'axe PD-1/PD-L1 : Study of phenotypic and functional homologies of EBV latency III B-lymphocytes with regulatory B cells, involvement of the PD-1 / PD-L1 axis.

Degree: Docteur es, Immunologie, Cancérologie, Virologie, 2017, Limoges

Le virus d’Epstein-Barr (EBV) est le premier virus transformant à avoir été identifié chez l’Homme. Il infecte plus de 90% de la population adulte mondiale,… (more)

Subjects/Keywords: EBV; Latence III; IL-10; Immunosuppression; Bregs; Tregs; Axe PD-1/PD-L1; EBV; Latency III; IL-10; Immunosuppression; Bregs; Tregs; PD-1/PD-L1axis; 615.37; 616.994

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Auclair, H. (2017). Etude des homologies phénotypiques et fonctionnelles des lymphocytes B en latence III de l'EBV avec les cellules B régulatrices, implication de l'axe PD-1/PD-L1 : Study of phenotypic and functional homologies of EBV latency III B-lymphocytes with regulatory B cells, involvement of the PD-1 / PD-L1 axis. (Doctoral Dissertation). Limoges. Retrieved from http://www.theses.fr/2017LIMO0032

Chicago Manual of Style (16th Edition):

Auclair, Héloïse. “Etude des homologies phénotypiques et fonctionnelles des lymphocytes B en latence III de l'EBV avec les cellules B régulatrices, implication de l'axe PD-1/PD-L1 : Study of phenotypic and functional homologies of EBV latency III B-lymphocytes with regulatory B cells, involvement of the PD-1 / PD-L1 axis.” 2017. Doctoral Dissertation, Limoges. Accessed January 19, 2021. http://www.theses.fr/2017LIMO0032.

MLA Handbook (7th Edition):

Auclair, Héloïse. “Etude des homologies phénotypiques et fonctionnelles des lymphocytes B en latence III de l'EBV avec les cellules B régulatrices, implication de l'axe PD-1/PD-L1 : Study of phenotypic and functional homologies of EBV latency III B-lymphocytes with regulatory B cells, involvement of the PD-1 / PD-L1 axis.” 2017. Web. 19 Jan 2021.

Vancouver:

Auclair H. Etude des homologies phénotypiques et fonctionnelles des lymphocytes B en latence III de l'EBV avec les cellules B régulatrices, implication de l'axe PD-1/PD-L1 : Study of phenotypic and functional homologies of EBV latency III B-lymphocytes with regulatory B cells, involvement of the PD-1 / PD-L1 axis. [Internet] [Doctoral dissertation]. Limoges; 2017. [cited 2021 Jan 19]. Available from: http://www.theses.fr/2017LIMO0032.

Council of Science Editors:

Auclair H. Etude des homologies phénotypiques et fonctionnelles des lymphocytes B en latence III de l'EBV avec les cellules B régulatrices, implication de l'axe PD-1/PD-L1 : Study of phenotypic and functional homologies of EBV latency III B-lymphocytes with regulatory B cells, involvement of the PD-1 / PD-L1 axis. [Doctoral Dissertation]. Limoges; 2017. Available from: http://www.theses.fr/2017LIMO0032


Queens University

26. Sanwalka, Daniel. A Novel Mechanism of Tumour Cell Drug Resistance Induced by the Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint .

Degree: Biomedical and Molecular Sciences, Queens University

 Immune checkpoints are regulators of the immune system that are critical for self-tolerance and prevention of autoimmunity. The programmed death receptor-1 (PD-1)/programmed death ligand-1 (PD-L1)… (more)

Subjects/Keywords: PD-1 ; PD-L1 ; Autophagy ; Drug Resistance

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sanwalka, D. (n.d.). A Novel Mechanism of Tumour Cell Drug Resistance Induced by the Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint . (Thesis). Queens University. Retrieved from http://hdl.handle.net/1974/24309

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sanwalka, Daniel. “A Novel Mechanism of Tumour Cell Drug Resistance Induced by the Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint .” Thesis, Queens University. Accessed January 19, 2021. http://hdl.handle.net/1974/24309.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sanwalka, Daniel. “A Novel Mechanism of Tumour Cell Drug Resistance Induced by the Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint .” Web. 19 Jan 2021.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Sanwalka D. A Novel Mechanism of Tumour Cell Drug Resistance Induced by the Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint . [Internet] [Thesis]. Queens University; [cited 2021 Jan 19]. Available from: http://hdl.handle.net/1974/24309.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Sanwalka D. A Novel Mechanism of Tumour Cell Drug Resistance Induced by the Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint . [Thesis]. Queens University; Available from: http://hdl.handle.net/1974/24309

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


Texas Medical Center

27. Bartkowiak, Todd. Novel Imaging-Based Techniques Reveal a Role for PD-1/PD-L1 in Tumor Immune Surveillance in the Lung.

Degree: MS, 2013, Texas Medical Center

  The binding of immune inhibitory receptor Programmed Death 1 (PD-1) on T cells to its ligand PD-L1 has been implicated as a major contributor… (more)

Subjects/Keywords: PD-1; PD-L1; Intravital microscopy; Tumor immune surveillance; Immunotherapy; Immunoprophylaxis and Therapy; Investigative Techniques; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bartkowiak, T. (2013). Novel Imaging-Based Techniques Reveal a Role for PD-1/PD-L1 in Tumor Immune Surveillance in the Lung. (Thesis). Texas Medical Center. Retrieved from https://digitalcommons.library.tmc.edu/utgsbs_dissertations/354

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Bartkowiak, Todd. “Novel Imaging-Based Techniques Reveal a Role for PD-1/PD-L1 in Tumor Immune Surveillance in the Lung.” 2013. Thesis, Texas Medical Center. Accessed January 19, 2021. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/354.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Bartkowiak, Todd. “Novel Imaging-Based Techniques Reveal a Role for PD-1/PD-L1 in Tumor Immune Surveillance in the Lung.” 2013. Web. 19 Jan 2021.

Vancouver:

Bartkowiak T. Novel Imaging-Based Techniques Reveal a Role for PD-1/PD-L1 in Tumor Immune Surveillance in the Lung. [Internet] [Thesis]. Texas Medical Center; 2013. [cited 2021 Jan 19]. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/354.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Bartkowiak T. Novel Imaging-Based Techniques Reveal a Role for PD-1/PD-L1 in Tumor Immune Surveillance in the Lung. [Thesis]. Texas Medical Center; 2013. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/354

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

28. Raffo Iraolagoitia, Ximena Lucía. Rol de las células NK en el desarrollo de la respuesta inmune adaptativa mediada por LT CD8 contra antígenos tumorales.

Degree: Farmacia y Bioquímica, 2016, Universidad de Buenos Aires

Despite the classical function of NK cells in the elimination of tumors, evidence for a regulatory role for NK cells has been emerging in different… (more)

Subjects/Keywords: Células NK; LT CD8; DCs; PD-1/PD-L1; Inmunidad anti-tumoral; Ciencia de la vida

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Raffo Iraolagoitia, X. L. (2016). Rol de las células NK en el desarrollo de la respuesta inmune adaptativa mediada por LT CD8 contra antígenos tumorales. (Thesis). Universidad de Buenos Aires. Retrieved from http://repositoriouba.sisbi.uba.ar/gsdl/cgi-bin/library.cgi?a=d&c=posgrauba&cl=CL1&d=HWA_1161 ; http://repositoriouba.sisbi.uba.ar/gsdl/collect/posgrauba/index/assoc/HWA_1161.dir/1161.PDF

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Raffo Iraolagoitia, Ximena Lucía. “Rol de las células NK en el desarrollo de la respuesta inmune adaptativa mediada por LT CD8 contra antígenos tumorales.” 2016. Thesis, Universidad de Buenos Aires. Accessed January 19, 2021. http://repositoriouba.sisbi.uba.ar/gsdl/cgi-bin/library.cgi?a=d&c=posgrauba&cl=CL1&d=HWA_1161 ; http://repositoriouba.sisbi.uba.ar/gsdl/collect/posgrauba/index/assoc/HWA_1161.dir/1161.PDF.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Raffo Iraolagoitia, Ximena Lucía. “Rol de las células NK en el desarrollo de la respuesta inmune adaptativa mediada por LT CD8 contra antígenos tumorales.” 2016. Web. 19 Jan 2021.

Vancouver:

Raffo Iraolagoitia XL. Rol de las células NK en el desarrollo de la respuesta inmune adaptativa mediada por LT CD8 contra antígenos tumorales. [Internet] [Thesis]. Universidad de Buenos Aires; 2016. [cited 2021 Jan 19]. Available from: http://repositoriouba.sisbi.uba.ar/gsdl/cgi-bin/library.cgi?a=d&c=posgrauba&cl=CL1&d=HWA_1161 ; http://repositoriouba.sisbi.uba.ar/gsdl/collect/posgrauba/index/assoc/HWA_1161.dir/1161.PDF.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Raffo Iraolagoitia XL. Rol de las células NK en el desarrollo de la respuesta inmune adaptativa mediada por LT CD8 contra antígenos tumorales. [Thesis]. Universidad de Buenos Aires; 2016. Available from: http://repositoriouba.sisbi.uba.ar/gsdl/cgi-bin/library.cgi?a=d&c=posgrauba&cl=CL1&d=HWA_1161 ; http://repositoriouba.sisbi.uba.ar/gsdl/collect/posgrauba/index/assoc/HWA_1161.dir/1161.PDF

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universitat Autònoma de Barcelona

29. Bassas Freixas, Patricia. Caracterización de la expresión de ácido ribonucleico mensajero en distintos subtipos histológicos de carcinoma basocelular.

Degree: Departament de Medicina i Cirurgia Animals, 2018, Universitat Autònoma de Barcelona

 Basal cell carcinomas (BCC) are the most common cancers worldwide and their incidence is increasing annualy. A subset of BCC behaves more aggressively and are… (more)

Subjects/Keywords: Carcinoma basocel·lular; Carcinoma basocelular; Basal cell carcinoma; Pd-1; PD-L1; RNA-sequencing; Ciències de la Salut; 616.5

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bassas Freixas, P. (2018). Caracterización de la expresión de ácido ribonucleico mensajero en distintos subtipos histológicos de carcinoma basocelular. (Thesis). Universitat Autònoma de Barcelona. Retrieved from http://hdl.handle.net/10803/665811

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Bassas Freixas, Patricia. “Caracterización de la expresión de ácido ribonucleico mensajero en distintos subtipos histológicos de carcinoma basocelular.” 2018. Thesis, Universitat Autònoma de Barcelona. Accessed January 19, 2021. http://hdl.handle.net/10803/665811.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Bassas Freixas, Patricia. “Caracterización de la expresión de ácido ribonucleico mensajero en distintos subtipos histológicos de carcinoma basocelular.” 2018. Web. 19 Jan 2021.

Vancouver:

Bassas Freixas P. Caracterización de la expresión de ácido ribonucleico mensajero en distintos subtipos histológicos de carcinoma basocelular. [Internet] [Thesis]. Universitat Autònoma de Barcelona; 2018. [cited 2021 Jan 19]. Available from: http://hdl.handle.net/10803/665811.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Bassas Freixas P. Caracterización de la expresión de ácido ribonucleico mensajero en distintos subtipos histológicos de carcinoma basocelular. [Thesis]. Universitat Autònoma de Barcelona; 2018. Available from: http://hdl.handle.net/10803/665811

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Manchester

30. Oguejiofor, Kenneth Kenechukwu. Prognostic markers in oropharyngeal cancers.

Degree: PhD, 2016, University of Manchester

 Introduction: Human papillomavirus (HPV) is changing the prevalence, survival and treatment paradigms in oropharyngeal squamous cell carcinoma (OPSCC). Improved survival of patients with HPV positive… (more)

Subjects/Keywords: 616.99; Oropharyngeal cancers (OPSCC); Human papilloma virus (HPV); Tumour infiltrating lymphocytes (TIL); Hypoxia; PD-1/PD-L1; Multiplex immunohistochemistry

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Oguejiofor, K. K. (2016). Prognostic markers in oropharyngeal cancers. (Doctoral Dissertation). University of Manchester. Retrieved from https://www.research.manchester.ac.uk/portal/en/theses/prognostic-markers-in-oropharyngeal-cancers(fda96224-657d-4049-ae6c-50db33a5388a).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.684833

Chicago Manual of Style (16th Edition):

Oguejiofor, Kenneth Kenechukwu. “Prognostic markers in oropharyngeal cancers.” 2016. Doctoral Dissertation, University of Manchester. Accessed January 19, 2021. https://www.research.manchester.ac.uk/portal/en/theses/prognostic-markers-in-oropharyngeal-cancers(fda96224-657d-4049-ae6c-50db33a5388a).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.684833.

MLA Handbook (7th Edition):

Oguejiofor, Kenneth Kenechukwu. “Prognostic markers in oropharyngeal cancers.” 2016. Web. 19 Jan 2021.

Vancouver:

Oguejiofor KK. Prognostic markers in oropharyngeal cancers. [Internet] [Doctoral dissertation]. University of Manchester; 2016. [cited 2021 Jan 19]. Available from: https://www.research.manchester.ac.uk/portal/en/theses/prognostic-markers-in-oropharyngeal-cancers(fda96224-657d-4049-ae6c-50db33a5388a).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.684833.

Council of Science Editors:

Oguejiofor KK. Prognostic markers in oropharyngeal cancers. [Doctoral Dissertation]. University of Manchester; 2016. Available from: https://www.research.manchester.ac.uk/portal/en/theses/prognostic-markers-in-oropharyngeal-cancers(fda96224-657d-4049-ae6c-50db33a5388a).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.684833

[1] [2] [3]

.